APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transforming Growth Factor Beta 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transforming Growth Factor Beta 2 Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchTransforming Growth Factor Beta 2 Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Transforming Growth Factor Beta 2 Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Transforming Growth Factor Beta 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transforming Growth Factor Beta 2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Transforming Growth Factor Beta 2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Transforming Growth Factor Beta 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transforming Growth Factor Beta 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transforming Growth Factor Beta 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transforming Growth Factor Beta 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transforming Growth Factor Beta 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transforming Growth Factor Beta 2 market include Autotelic Inc, Isarna Therapeutics GmbH, Genzyme Corp and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Transforming Growth Factor Beta 2 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transforming Growth Factor Beta 2 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transforming Growth Factor Beta 2 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Transforming Growth Factor Beta 2 market.

Transforming Growth Factor Beta 2 Segment by Company

Autotelic Inc

Isarna Therapeutics GmbH

Genzyme Corp

Novartis AG

Transforming Growth Factor Beta 2 Segment by Type

XOMA-089

Trabedersen

ISTH-0047

Others

Transforming Growth Factor Beta 2 Segment by Application

Glioblastoma Multiforme

Liver Fibrosis

Melanoma

Open-Angle Glaucoma

Breast Cancer

Others

Transforming Growth Factor Beta 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Transforming Growth Factor Beta 2 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Transforming Growth Factor Beta 2 key companies, revenue, market share, and recent developments.

3. To split the Transforming Growth Factor Beta 2 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Transforming Growth Factor Beta 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transforming Growth Factor Beta 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Transforming Growth Factor Beta 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transforming Growth Factor Beta 2 industry.

Chapter 3: Detailed analysis of Transforming Growth Factor Beta 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Transforming Growth Factor Beta 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Transforming Growth Factor Beta 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transforming Growth Factor Beta 2 Industry Trends Table 2. Transforming Growth Factor Beta 2 Industry Drivers Table 3. Transforming Growth Factor Beta 2 Industry Opportunities and Challenges Table 4. Transforming Growth Factor Beta 2 Industry Restraints Table 5. Global Transforming Growth Factor Beta 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transforming Growth Factor Beta 2 Revenue Share by Company (2021-2026) Table 7. Global Transforming Growth Factor Beta 2 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Transforming Growth Factor Beta 2 Key Company Manufacturing Base & Headquarters Table 9. Global Transforming Growth Factor Beta 2 Company, Product Type & Application Table 10. Global Transforming Growth Factor Beta 2 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Transforming Growth Factor Beta 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of XOMA-089 Table 15. Significant Companies of Trabedersen Table 16. Significant Companies of ISTH-0047 Table 17. Significant Companies of Others Table 18. Global Transforming Growth Factor Beta 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Transforming Growth Factor Beta 2 Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Transforming Growth Factor Beta 2 Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Transforming Growth Factor Beta 2 Sales Value Share by Type (2021-2026) Table 22. Global Transforming Growth Factor Beta 2 Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Glioblastoma Multiforme Table 24. Significant Companies of Liver Fibrosis Table 25. Significant Companies of Melanoma Table 26. Significant Companies of Open-Angle Glaucoma Table 27. Significant Companies of Breast Cancer Table 28. Significant Companies of Others Table 29. Global Transforming Growth Factor Beta 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Transforming Growth Factor Beta 2 Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Transforming Growth Factor Beta 2 Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Transforming Growth Factor Beta 2 Sales Value Share by Application (2021-2026) Table 33. Global Transforming Growth Factor Beta 2 Sales Value Share by Application (2027-2032) Table 34. Global Transforming Growth Factor Beta 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Transforming Growth Factor Beta 2 Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Transforming Growth Factor Beta 2 Sales Value Share by Region (2021-2026) Table 37. Global Transforming Growth Factor Beta 2 Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Transforming Growth Factor Beta 2 Sales Value Share by Region (2027-2032) Table 39. Global Transforming Growth Factor Beta 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Transforming Growth Factor Beta 2 Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Transforming Growth Factor Beta 2 Sales Value Market Share by Country (2021-2026) Table 42. Global Transforming Growth Factor Beta 2 Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Transforming Growth Factor Beta 2 Sales Value Market Share by Country (2027-2032) Table 44. Autotelic Inc Company Information Table 45. Autotelic Inc Business Overview Table 46. Autotelic Inc Transforming Growth Factor Beta 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Autotelic Inc Transforming Growth Factor Beta 2 Product Portfolio Table 48. Autotelic Inc Recent Development Table 49. Isarna Therapeutics GmbH Company Information Table 50. Isarna Therapeutics GmbH Business Overview Table 51. Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Product Portfolio Table 53. Isarna Therapeutics GmbH Recent Development Table 54. Genzyme Corp Company Information Table 55. Genzyme Corp Business Overview Table 56. Genzyme Corp Transforming Growth Factor Beta 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Genzyme Corp Transforming Growth Factor Beta 2 Product Portfolio Table 58. Genzyme Corp Recent Development Table 59. Novartis AG Company Information Table 60. Novartis AG Business Overview Table 61. Novartis AG Transforming Growth Factor Beta 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Novartis AG Transforming Growth Factor Beta 2 Product Portfolio Table 63. Novartis AG Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Transforming Growth Factor Beta 2 Product Image Figure 2. Global Transforming Growth Factor Beta 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transforming Growth Factor Beta 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Transforming Growth Factor Beta 2 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. XOMA-089 Image Figure 8. Trabedersen Image Figure 9. ISTH-0047 Image Figure 10. Others Image Figure 11. Global Transforming Growth Factor Beta 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Transforming Growth Factor Beta 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Transforming Growth Factor Beta 2 Sales Value Share by Type (2021-2032) Figure 14. Glioblastoma Multiforme Image Figure 15. Liver Fibrosis Image Figure 16. Melanoma Image Figure 17. Open-Angle Glaucoma Image Figure 18. Breast Cancer Image Figure 19. Others Image Figure 20. Global Transforming Growth Factor Beta 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Transforming Growth Factor Beta 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Transforming Growth Factor Beta 2 Sales Value Share by Application (2021-2032) Figure 23. Global Transforming Growth Factor Beta 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Transforming Growth Factor Beta 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Transforming Growth Factor Beta 2 Sales Value (2021-2032) & (US$ Million) Figure 26. North America Transforming Growth Factor Beta 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Transforming Growth Factor Beta 2 Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Transforming Growth Factor Beta 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Transforming Growth Factor Beta 2 Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Transforming Growth Factor Beta 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Transforming Growth Factor Beta 2 Sales Value (2021-2032) & (US$ Million) Figure 32. South America Transforming Growth Factor Beta 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Transforming Growth Factor Beta 2 Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Transforming Growth Factor Beta 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • XOMA-089
  • Trabedersen
  • ISTH-0047
  • Others
Applications
  • Glioblastoma Multiforme
  • Liver Fibrosis
  • Melanoma
  • Open-Angle Glaucoma
  • Breast Cancer
  • Others
Companies covered
  • Autotelic Inc
  • Isarna Therapeutics GmbH
  • Genzyme Corp
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transforming Growth Factor Beta 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transforming Growth Factor Beta 2 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Transforming Growth Factor Beta 2 Market Dynamics
  1. 2.1 Transforming Growth Factor Beta 2 Industry Trends
  2. 2.2 Transforming Growth Factor Beta 2 Industry Drivers
  3. 2.3 Transforming Growth Factor Beta 2 Industry Opportunities and Challenges
  4. 2.4 Transforming Growth Factor Beta 2 Industry Restraints
3 Transforming Growth Factor Beta 2 Market by Company
  1. 3.1 Global Transforming Growth Factor Beta 2 Company Revenue Ranking in 2025
  2. 3.2 Global Transforming Growth Factor Beta 2 Revenue by Company (2021-2026)
  3. 3.3 Global Transforming Growth Factor Beta 2 Company Ranking (2024-2026)
  4. 3.4 Global Transforming Growth Factor Beta 2 Company Manufacturing Base and Headquarters
  5. 3.5 Global Transforming Growth Factor Beta 2 Company Product Type and Application
  6. 3.6 Global Transforming Growth Factor Beta 2 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Transforming Growth Factor Beta 2 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Transforming Growth Factor Beta 2 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Transforming Growth Factor Beta 2 Market by Type
  1. 4.1 Transforming Growth Factor Beta 2 Type Introduction
  2. 4.1.1 XOMA-089
  3. 4.1.2 Trabedersen
  4. 4.1.3 ISTH-0047
  5. 4.1.4 Others
  6. 4.2 Global Transforming Growth Factor Beta 2 Sales Value by Type
  7. 4.2.1 Global Transforming Growth Factor Beta 2 Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Transforming Growth Factor Beta 2 Sales Value by Type (2021-2032)
  9. 4.2.3 Global Transforming Growth Factor Beta 2 Sales Value Share by Type (2021-2032)
5 Transforming Growth Factor Beta 2 Market by Application
  1. 5.1 Transforming Growth Factor Beta 2 Application Introduction
  2. 5.1.1 Glioblastoma Multiforme
  3. 5.1.2 Liver Fibrosis
  4. 5.1.3 Melanoma
  5. 5.1.4 Open-Angle Glaucoma
  6. 5.1.5 Breast Cancer
  7. 5.1.6 Others
  8. 5.2 Global Transforming Growth Factor Beta 2 Sales Value by Application
  9. 5.2.1 Global Transforming Growth Factor Beta 2 Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Transforming Growth Factor Beta 2 Sales Value by Application (2021-2032)
  11. 5.2.3 Global Transforming Growth Factor Beta 2 Sales Value Share by Application (2021-2032)
6 Transforming Growth Factor Beta 2 Regional Value Analysis
  1. 6.1 Global Transforming Growth Factor Beta 2 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transforming Growth Factor Beta 2 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Transforming Growth Factor Beta 2 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Transforming Growth Factor Beta 2 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transforming Growth Factor Beta 2 Sales Value (2021-2032)
  7. 6.3.2 North America Transforming Growth Factor Beta 2 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Transforming Growth Factor Beta 2 Sales Value (2021-2032)
  10. 6.4.2 Europe Transforming Growth Factor Beta 2 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Transforming Growth Factor Beta 2 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Transforming Growth Factor Beta 2 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Transforming Growth Factor Beta 2 Sales Value (2021-2032)
  16. 6.6.2 South America Transforming Growth Factor Beta 2 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Transforming Growth Factor Beta 2 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Transforming Growth Factor Beta 2 Sales Value Share by Country, 2025 VS 2032
7 Transforming Growth Factor Beta 2 Country-level Value Analysis
  1. 7.1 Global Transforming Growth Factor Beta 2 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transforming Growth Factor Beta 2 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Transforming Growth Factor Beta 2 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Transforming Growth Factor Beta 2 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Transforming Growth Factor Beta 2 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Transforming Growth Factor Beta 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Transforming Growth Factor Beta 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Autotelic Inc
  2. 8.1.1 Autotelic Inc Company Information
  3. 8.1.2 Autotelic Inc Business Overview
  4. 8.1.3 Autotelic Inc Transforming Growth Factor Beta 2 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Autotelic Inc Transforming Growth Factor Beta 2 Product Portfolio
  6. 8.1.5 Autotelic Inc Recent Developments
  7. 8.2 Isarna Therapeutics GmbH
  8. 8.2.1 Isarna Therapeutics GmbH Company Information
  9. 8.2.2 Isarna Therapeutics GmbH Business Overview
  10. 8.2.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Product Portfolio
  12. 8.2.5 Isarna Therapeutics GmbH Recent Developments
  13. 8.3 Genzyme Corp
  14. 8.3.1 Genzyme Corp Company Information
  15. 8.3.2 Genzyme Corp Business Overview
  16. 8.3.3 Genzyme Corp Transforming Growth Factor Beta 2 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genzyme Corp Transforming Growth Factor Beta 2 Product Portfolio
  18. 8.3.5 Genzyme Corp Recent Developments
  19. 8.4 Novartis AG
  20. 8.4.1 Novartis AG Company Information
  21. 8.4.2 Novartis AG Business Overview
  22. 8.4.3 Novartis AG Transforming Growth Factor Beta 2 Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis AG Transforming Growth Factor Beta 2 Product Portfolio
  24. 8.4.5 Novartis AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst